Barbara Lipert

Cancer Society of New Zealand — New Zealand

Biochemistry, Genetics and Molecular Biology · Life Sciences

9h-index622citations20works1.32yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

DNA Repair Mechanisms(4), Advanced biosensing and bioanalysis techniques(3), Monoclonal and Polyclonal Antibodies Research(3), Nanoparticles: synthesis and applications(2), RNA Research and Splicing(2)

Publications20 total

RaDRI: A computational model for radiosensitisation by DNA double strand break repair inhibitors
2026Open Access
Abstract B050: Identification of novel molecular vulnerabilities in colorectal cancer through integrated transcriptomic profiling and functional genomics
Molecular Cancer Therapeutics·2025
Integrated transcriptomic and functional modeling reveals AKT and mTOR synergy in colorectal cancer
Scientific Reports·2025Open Access
Abstract 2973: Discovery of novel synthetic lethal targets for effective and safe colorectal cancer therapies
Cancer Research·2025
CRISPR screens with trastuzumab emtansine in HER2-positive breast cancer cell lines reveal new insights into drug resistance
Breast Cancer Research·2025· 5 citedOpen Access
417 (PB405): Exploring Synthetic Lethality and novel drug combinations in Patient-Derived Cells
European Journal of Cancer·2024
Identification of 6-Anilino Imidazo[4,5-<i>c</i>]pyridin-2-ones as Selective DNA-Dependent Protein Kinase Inhibitors and Their Application as Radiosensitizers
Journal of Medicinal Chemistry·2024· 4 citedOpen Access
Functional genomics screens to identify genes involved in tolerance of tumour microenvironment stress
European Journal of Cancer·2020
Abstract 5853: Identification of <i>TSC1</i> and <i>TSC2</i> as potential determinants of sensitivity to trastuzumab emtansine
Cancer Research·2020
Mechanisms of resistance to trastuzumab emtansine (T-DM1) in HER2-positive breast cancer
British Journal of Cancer·2019· 276 citedOpen Access
Hypoxia-selective radiosensitisation by SN38023, a bioreductive prodrug of DNA-dependent protein kinase inhibitor IC87361
Biochemical Pharmacology·2019· 26 cited
Radiosensitization of head and neck squamous cell carcinoma lines by DNA-PK inhibitors is more effective than PARP-1 inhibition and is enhanced by SLFN11 and hypoxia
International Journal of Radiation Biology·2019· 43 cited
Functional CRISPR knockout screens for modifiers of sensitivity to trastuzumab emtansine
Annals of Oncology·2019· 1 cited
MCPIP1, alias Regnase-1 binds and cleaves mRNA of C/EBPβ
PLoS ONE·2017· 25 citedOpen Access
MCPIP1 contributes to clear cell renal cell carcinomas development
Angiogenesis·2017· 75 citedOpen Access
MCPIP1 RNase Is Aberrantly Distributed in Psoriatic Epidermis and Rapidly Induced by IL-17A
Journal of Investigative Dermatology·2016· 45 citedOpen Access
Effect of silver nanoparticles on human primary keratinocytes
nano Online·2016· 5 cited
Monocyte Chemoattractant Protein-Induced Protein 1 (MCPIP1) Enhances Angiogenic and Cardiomyogenic Potential of Murine Bone Marrow-Derived Mesenchymal Stem Cells
PLoS ONE·2015· 26 citedOpen Access
Monocyte chemoattractant protein-induced protein 1 impairs adipogenesis in 3T3-L1 cells
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research·2014· 36 citedOpen Access
Effect of silver nanoparticles on human primary keratinocytes
Biological Chemistry·2012· 55 citedOpen Access

Frequent Co-authors

Francis W. Hunter(7), Jolanta Jura(7), Stephen M. F. Jamieson(6), Michael P. Hay(4), Eliza Zimoląg(4), Joanna Szuszkiewicz(4), Marcin Serocki(4), Marcin Dulęba(4), Oleksii Bryzghalov(4), Maria J. Chmiel(4), Rafał Dziadziuszko(4), Andrzej Mazan(4), Hilary R. Barker(3), Tet Woo Lee(3), Way W. Wong(3), Benjamin D. Dickson(3), William R. Wilson(3), Kyla N. Siemens(3), Aziza Khan(3), Izabella Więckowska(3)